Afficher la notice abrégée

dc.contributor.authorBrauner, R.fr_FR
dc.contributor.authorDezegher, F.fr_FR
dc.date.accessioned2013-02-18T16:17:46Z
dc.date.available2013-02-18T16:17:46Z
dc.date.issued1993fr_FR
dc.identifier.citationBrauner, R. ; Dezegher, F., Croissance et maturation fœtales, Med Sci (Paris), 1993, Vol. 9, N° 3; p.271-276fr_FR
dc.identifier.issn1958-5381fr_FR
dc.identifier.urihttp://hdl.handle.net/10608/2909
dc.description.abstractPrenatal growth is under genetic, environmental and endocrine control. The maternal environment intervenes through physical constraints and through the transplacental transfer of oxygen and nutrients, that may be influenced. by maternal serum levels of insulin-like growth factor I (IGF-I). The placenta is crucial for fetal growth. Two hormones tonically secreted by the placenta, placental growth hormone and placental lactogen, appear to participate in maternal metabolism and IGF production, and thus in fetal growth. Fetal insulin and IGFs emerge as the principal endocrine regulators of prenatal growth, whereas fetal pituitary growth hormone plays a minor role. Glucocorticoids and thyroid hormones accelerate the velocity of fetal maturation. In case of threatening premature birth, glucocorticoids and thyroid stimulating hormone-releasing hormone (TRH) can be administered to accelerate fetal maturation, in an attempt to prevent neonatal morbidity.fr
dc.language.isofrfr_FR
dc.publisherJohn Libbey Eurotext, Montrougefr_FR
dc.rightsArticle en libre accèsfr
dc.rightsMédecine/Sciences - Inserm - SRMSfr
dc.sourceM/S. Médecine sciences [revue papier, ISSN : 0767-0974], 1993, Vol. 9, N° 3; p.271-276fr_FR
dc.titleCroissance et maturation fœtalesfr
dc.typeArticlefr_FR
dc.identifier.doi10.4267/10608/2909


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée